.
MergerLinks Header Logo

Announced

Completed

Thoma Bravo completed a minority investment in Summa Equity-backed LOGEX.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Software

Single Bidder

Private

Minority

software services

healthcare analytics

Acquisition

Cross Border

Completed

Netherlands

Private Equity

Venture Capital

Friendly

Synopsis

Edit

Thoma Bravo, a private equity firm, completed a minority investment in Summa Equity-backed LOGEX, a healthcare analytics company. Financial terms were not disclosed. "Our mission is to turn data into better healthcare. There is an urgent need for stronger, more resilient, and more accessible health systems in Europe. We are already active in 10 European markets and we know we can play a meaningful role in evolving healthcare in Europe and making systems interoperable for improved international collaboration if we can expand further. Thoma Bravo, with their deep technical knowledge and their expertise in operational excellence, will be a fantastic partner to help us achieve that goal," Philipp Jan Flach, LOGEX CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US